AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom

January 10, 2020 GMT

SAN DIEGO--(BUSINESS WIRE)--Jan 10, 2020--

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI’s sequencing products, including the DNBSeq-400 (also known as MGISeq-2000), DNBSeq-T7, and related chemistry reagents.

The first complaint was filed against MGI Tech Co., Ltd. and Latvia MGI Tech SIA in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom alleging infringement of four patents: EP 1 530 578 B1, EP 1 828 412 B2, EP 2 021 415 B1, and EP 3 002 289 B1. The second complaint was filed against Latvia MGI Tech SIA in the Patent and Market Court in Sweden alleging infringement of EP 3 002 289 B1. The patents cover Illumina’s proprietary sequencing-by-synthesis chemistry.

Related patent suits are pending in Denmark, Germany, Switzerland, Turkey and the United States.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200110005033/en/

CONTACT: Illumina, Inc.

Investors:

Jacquie Ross, CFA

+1-858-255-5243

IR@illumina.com

or

Media:

Eric Endicott

858-882-6822

pr@illumina.com

or

Media – Europe, Middle East & Africa:

Karen Birmingham

+44(0) 7500105665

kbirmingham@illumina.com

KEYWORD: CALIFORNIA NORTH AMERICA UNITED STATES UNITED KINGDOM EUROPE SWEDEN

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH GENETICS PROFESSIONAL SERVICES LEGAL

SOURCE: Illumina, Inc.

Copyright Business Wire 2020.

PUB: 01/10/2020 09:00 AM/DISC: 01/10/2020 09:01 AM

http://www.businesswire.com/news/home/20200110005033/en